Literature DB >> 3242579

A single dose pharmacokinetic study of Gastrobid Continus and Maxolon in the perioperative period.

T H Madej1, F R Ellis, I Tring.   

Abstract

1. A single dose pharmacokinetic comparison of Gastrobid Continus and Maxolon was carried out perioperatively in two groups of 12 gynaecological patients; each group comprised six patients for major surgery and six patients for minor surgery. 2. The areas under the plasma drug concentration-time curves were similar after both preparations. 3. In the minor surgery group after Gastrobid Continus the plasma drug concentration-time curve was wider at half Cmax (P less than 0.01), Cmax was reduced (P less than 0.05) and delayed (median (range) 4 (3-6) vs 2.5 (2-4) h) compared with Maxolon, and the log of the metoclopramide concentration did not have a linear relationship with time from 2-9 h. 4. A flattening of the plasma drug concentration-time curve was the only difference between the two preparations in the major surgery groups. 5. The plasma drug concentration-time curve was wider (P less than 0.05) at at half Cmax in the minor compared with the major surgery groups receiving Gastrobid Continus. 6. Pharmacokinetic parameters were similar for Maxolon in both surgical groups. 7. Sustained release pharmacokinetic characteristics were most pronounced in the minor surgery group which did not receive opiate medication but in which there were more moderately anxious patients prior to induction and in whom anxiety may have delayed gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242579      PMCID: PMC1386590          DOI: 10.1111/j.1365-2125.1988.tb05314.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Inhibition of gastric emptying and drug absorption by narcotic analgesics.

Authors:  W S Nimmo; R C Heading; J Wilson; P Tothill; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

2.  Studies of drugs given before anaesthesia. XXIV: Metocloramide with morphine and pethidine.

Authors:  R A Assaf; R S Clarke; J W Dundee; I O Samuel
Journal:  Br J Anaesth       Date:  1974-07       Impact factor: 9.166

3.  The premedicant and anti-emetic action of metoclopramide.

Authors:  J W Dundee; R S Clarke
Journal:  Postgrad Med J       Date:  1973-07       Impact factor: 2.401

4.  Metoclopramide--side effects and safety.

Authors:  O P Robinson
Journal:  Postgrad Med J       Date:  1973-07       Impact factor: 2.401

5.  Metoclopramide in the prevention of post-operative nausea and vomiting.

Authors:  A J Handley
Journal:  Br J Clin Pract       Date:  1967-09-09

6.  Concentration effect studies with oral metoclopramide.

Authors:  D N Bateman; C Kahn; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

7.  Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.

Authors:  D N Bateman; C Kahn; K Mashiter; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

8.  Clinical trials of metoclopramide (Maxolon) as an antiemetic in anaesthesia.

Authors:  F R Ellis; A A Spence
Journal:  Anaesthesia       Date:  1970-07       Impact factor: 6.955

9.  Dystonic reactions and the pharmacokinetics of metoclopramide in children.

Authors:  D N Bateman; A W Craft; E Nicholson; A D Pearson
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

10.  An evaluation of metoclopramide (Maxolon) as an anti-emetic in minor gynaecological surgery.

Authors:  Z P Shah; J Wilson
Journal:  Br J Anaesth       Date:  1972-08       Impact factor: 9.166

View more
  1 in total

Review 1.  Pharmacokinetic optimisation of antiemetic therapy.

Authors:  M Campbell; D N Bateman
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.